Skip to main content

Articles

Page 1 of 11

  1. Healthcare services across the world have been deeply impacted by the COVID-19 pandemic. In primary care, community pharmacists have had an important role in the frontline healthcare response to the pandemic.

    Authors: Claire Durand, Eric Douriez, Aude Chappuis, Frédérique Poulain, Yazdan Yazdanpanah, Sylvie Lariven, François-Xavier Lescure and Nathan Peiffer-Smadja
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:43
  2. Authors: Belachew Tefera, Belachew Bacha, Sileshi Belew, Rafaella Ravinetto, Tenaw Andualem, Zerihun Abegaz, Ayalew Zelelew, Gudeta Uma, Tadese Setegn, Abdisa Hunduma, Dinsefa Jemal, Diriba Daba and Bizuayehu Belete
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:41

    The original article was published in Journal of Pharmaceutical Policy and Practice 2022 15:17

  3. Pharmacy practice research publications has increased significantly in the last decade. This is also true for Middle Eastern countries.

    Authors: Daneh Obaid, Faris El-Dahiyat and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:40
  4. To evaluate knowledge, attitude and perception of community pharmacists towards pharmacogenomics services.

    Authors: Usman Abubakar, Lienarrubini Subramaniam, Abdulkadir Ayinla, Mobolaji Nurudeen Ambali, Dzul Azri Mohamed Noor, Nur Aizati Athirah Daud, Hauwa Kulu Isah and Hiba A. Al-Shami
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:39
  5. Pharmacists in high-income countries routinely provide efficient pharmacy or pharmaceutical care services that are known to improve clinical, economic, and humanistic outcomes (ECHO) of patients. However, phar...

    Authors: Sunil Shrestha, Rajeev Shrestha, Ali Ahmed, Binaya Sapkota, Asmita Priyadarshini Khatiwada, Christina Malini Christopher, Parbati Thapa, Bhuvan KC, Ali Qais Blebil, Saval Khanal and Vibhu Paudyal
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:37
  6. Despite calls for the use of additional real-world evidence (RWE) during drug development, rates of inclusion at the regulatory stage remain low. The medicine adoption model suggests that providing additional ...

    Authors: Ravi Jandhyala
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:36
  7. Asthma is a significant public health issue that poses a substantial health and economic burden. Despite the availability of effective asthma medications, its management remain suboptimal. Recent asthma guidel...

    Authors: Amira S. A. Said, Nadia Hussain, Zelal Kharaba, Amal H. I. Al Haddad, Lamiaa N. Abdelaty and Raghda R. S. Hussein
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:35

    The Correction to this article has been published in Journal of Pharmaceutical Policy and Practice 2022 15:38

  8. COVID-19 has led to restrictions on movements and lockdown measures, which have resulted to higher utilization of over-the-counter drugs compared to prescription-only drugs. This study determined the prevalenc...

    Authors: Chidinma Ihuoma Amuzie, Kalu Ulu Kalu, Michael Izuka, Uche Ngozi Nwamoh, Uloaku Emma-Ukaegbu, Franklin Odini, Kingsley Metu, Chigozie Ozurumba and Ijeoma Nkem Okedo-Alex
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:34
  9. India, the country with the largest market availability of antimicrobial fixed-dose combinations (FDCs), banned certain antimicrobial FDCs in September 2018. Our objective was to examine the impact of Governme...

    Authors: Giorgia Sulis, Richeek Pradhan, Anita Kotwani and Sumanth Gandra
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:33
  10. While intravenous human immunoglobulin therapy is potentially lifesaving for rare diseases, the significant costs associated with its usage warrant due attention. This study evaluated the costs and prescribing...

    Authors: Shea Jiun Choo, Chun Zheng Ng, Yi Jing Ong, Kamariah Shamsinar Kamarul Baharin and Chee Tao Chang
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:31
  11. The use of pharmaceutical pictograms to enhance patients’ understanding of drug regimens has been proven effective in many countries. There are two reference systems for pictograms generally used in pharmacy: ...

    Authors: Margarita M. Gutierrez, Chanthawat Patikorn and Puree Anantachoti
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:30
  12. In countries with limited access to healthcare services, community pharmacists’ management of minor symptoms experienced by pregnant women could be beneficial in terms of alleviating the burden of other health...

    Authors: Asnakew Achaw Ayele, Md Shahidul Islam, Suzanne Cosh and Leah East
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:29
  13. Tension in the supply of highly consumed drugs for patients with COVID-19 (propofol, midazolam, curares) led the French government to set up a centralized supply of hospitals with distribution based on the num...

    Authors: Claire Chapuis, Rémy Collomp, Laura Albaladejo, Hugo Terrisse, Stéphane Honoré, Jean-Luc Bosson, Pierrick Bedouch and Pierre Albaladejo
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:28
  14. Canada has experienced a distinctly bifurcated pattern of (strong) opioid utilization post-2000, with multifold increases rendering it one of the world’s highest opioid consumption rates, followed by subsequen...

    Authors: Wayne Jones, Ridhwana Kaoser, David Rudoler and Benedikt Fischer
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:27
  15. People with weakened immune systems may not develop adequate protection after taking two doses of the mRNA-combined COVID-19 vaccine. The additional dose may improve the level of protection against Covid-19.

    Authors: Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Faris El-Dahiyat, Maimona Jairoun, Moyad Shahwan, Mena Al Ani, Mustafa Habeb and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:26
  16. Community pharmacies are widely distributed in the United Arab Emirates where community pharmacists’ (CPs’) perspectives on provision of extended community pharmacy services (ECPS) is not known. This study ass...

    Authors: Subish Palaian, Muaed Alomar, Nageeb Hassan and Fatima Boura
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:24
  17. Globally, hypertension is a major public health problem and a strong predictor of cardiovascular disease complications. To reduce and prevent complications from hypertension, it is important to adapt self-care...

    Authors: Tsegaye Melaku, Bodena Bayisa, Helen Fekeremaryam, Alemayehu Feyissa and Alemayehu Gutasa
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:23
  18. Harm with inappropriate and irrational use of medications is a global challenge. The need for and patient access to medicines optimisation services is apparent globally and amplified in India due to multiple r...

    Authors: Mansi Doshi, Minesh Parbat, Vibhu Paudyal and John Marriott
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:22
  19. Community pharmacists (CPs) are one of the frontline healthcare workers (HCWs) working diligently to provide much-needed services during the COVID-19 pandemic. Burnout was one of the detrimental outcomes of th...

    Authors: Dalal Youssef, Linda Abou-Abbas and Janet Youssef
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:21
  20. In 2019, more than $34.5 billion was spent on prescription drugs in Canada. However, little is known about the distribution of this spending across medications and settings (outpatient and inpatient) over time...

    Authors: Mark Hofmeister, Ashwinie Sivakumar, Fiona Clement, Kaleen N. Hayes, Michael Law, Jason R. Guertin, Heather L. Neville and Mina Tadrous
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:20
  21. Adverse drug event (ADE) reporting is a significant process to increase consumer care and consumer safety associated with the use of medicines. An in-depth investigation into low ADE reporting by consumers and...

    Authors: Tanattha Kitisopee, Jirunya Assanee, Bernard A. Sorofman and Suntaree Watcharadmrongkun
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:19
  22. Pharmaceutical advertising is not only considered a key factor in the successful launch of pharmaceutical products, but is also an important source of public health information with a significant impact on con...

    Authors: Nazila Yousefi, Zahra Sharif, Fateme Chahian, Tayebe Mombeini and Farzad Peiravian
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:18
  23. Medicines of poor quality are currently prevailing problems undermining the quality of health care services in veterinary and human medicine. In this study, physico-chemical quality of veterinary medicines was...

    Authors: Belachew Tefera, Belachew Bacha, Sileshi Belew, Raffaella Ravinetto, Tenaw Andualem, Zerihun Abegaz, Ayalew Zelelew, Gudeta Uma, Tadese Setegn, Abdisa Hunduma, Dinsefa Jemal, Diriba Daba and Bizuayehu Belete
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:17

    The Correction to this article has been published in Journal of Pharmaceutical Policy and Practice 2022 15:41

  24. Successful mass vaccination programmes are public health achievements of the contemporary world. While pharmaceutical companies are actively developing new vaccines, and demonstrating results of effectiveness ...

    Authors: Mathumalar Loganathan Fahrni, Intan An-Nisaa’ Ismail, Dalia Mohammed Refi, Ahmad Almeman, Norliana Che Yaakob, Kamaliah Md Saman, Nur Farhani Mansor, Noorasmah Noordin and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:16
  25. To determine how additional explanatory text (context) about drug side effects in a patient medication information handout affected comprehension and perceptions of risk and efficacy.

    Authors: Bridget Kelly, Amie O’Donoghue, Sarah Parvanta, Vanessa Boudewyns, Oluwamurewa Oguntimein, Carla Bann, Sue West, Janice Tzeng, Caroline Chandler, Gabriel Madson and Lauren McCormack
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:15
  26. The health supply chain system is essential for the optimum performance of the healthcare system. Despite increased investments in the health supply chain system, access to quality Essential Medicines and Heal...

    Authors: Eric Lugada, Henry Komakech, Irene Ochola, Shiela Mwebaze, Martin Olowo Oteba and Denis Okidi Ladwar
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:14
  27. The consistency and the quality of medicine labels are sought through the regulatory frameworks. This study aims at investigating the secondary labels of medicines based on the labeling regulations and guideli...

    Authors: Manori Jayasinghe, Thotawaththage Loshadhi Indunika Srilal, Deweni Guruge Pathmila Prasadi, Wickramasinghe Senanayakege Sachini Madushika, Samanda Marakkala Dileka Udyani Silva and Sewwandi Subasinghe
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:13
  28. The improper disposal of unused drugs can harm the environment and living beings. Programs such as drug take-back bins encourage people to dispose of unused medication at designated locations have increased. U...

    Authors: Tamara Vehige Calise, Sarah Levin Martin and Chloe Wingerter
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:12
  29. Currently, the private healthcare sector's role in healthcare delivery is growing in Ethiopia. However, there are limited studies on private healthcare sector drug use patterns. This study aimed to evaluate th...

    Authors: Getahun Asmamaw, Nahu Ejigu, Dinksew Tewihubo and Wondim Ayenew
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:11
  30. Multi- criteria decision analysis (MCDA) can assist policymakers in objectively choosing between alternative therapeutic options based on multiple value attributes. Our aim was to create an MCDA tool for the n...

    Authors: Baher Elezbawy, Ahmad Nader Fasseeh, Amal Sedrak, Randa Eldessouki, Mary Gamal, Mariam Eldebeiky, Hanaa Amer, Shimaa Akeel, Ahmad Morsy, Amira Amin, Amr Shafik, Sherif Abaza and Zoltán Kaló
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:10
  31. Community pharmacists are among the most accessible healthcare professionals and are likely to experience the full brunt of public health crises. In Lebanon, the COVID-19 pandemic, added to a severe economic m...

    Authors: Mohamad Alameddine, Karen Bou-Karroum and Mohamad Ali Hijazi
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:8
  32. Delays in producing discharge prescriptions have hindered the provision of bedside dispensing services (BEDISC) that enable medication reconciliation and pharmaceutical intervention, which is an important elem...

    Authors: Ai Ling Oh, Yi Jing Tan, Wan Choon Chong, Irene Yee Yew Chieng, Jaime Yoke May Chan, Boon Phiaw Kho, Mei Ing Theng and Crystal Sing Yee Tan
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:7
  33. The aim of the study was to investigate the common deficiencies observed in the Finished Pharmaceutical Product (FPP) section of generic product applications submitted to SAHPRA. The study was conducted retros...

    Authors: Lerato Moeti, Madira Litedu and Jacques Joubert
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:6
  34. Vaccines have become the best weapon for epidemic prevention and control in the absence of standard approved effective therapies. However, skepticism about the vaccine efficacy and safety is constantly reporte...

    Authors: Philippe Hanna, Aline Issa, Ziad Noujeim, Mira Hleyhel and Nadine Saleh
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:5
  35. During the early phase of the COVID-19 pandemic, antibiotic usage among COVID-19 patients was noted to be high in many countries. The objective of this study was to determine the prevalence of antibiotic usage...

    Authors: Izzati-Nadhirah Mohamad, Calvin Ke-Wen Wong, Chii-Chii Chew, E-Li Leong, Biing-Horng Lee, Cheng-Keat Moh, Komalah Chenasammy, Steven Chee-Loon Lim and Hong-Bee Ker
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:4
  36. Substandard and Falsified (SF) medical products are a growing global concern. They harm the individual patient, the healthcare system and the economy. The World Health Organisation (WHO) has highlighted contri...

    Authors: R. J. Moshoeshoe, G. M. Enslin and D. R. Katerere
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:3
  37. Globally, an estimated 8.1 million children under 5 years die annually in developing countries. Ensuring essential medicines are accessible and affordable to the population is key to saving lives. This study i...

    Authors: Shannice Mahadeo, Keshmika Narain, Lungelo Mhlongo, Desmaine Chetty, Lindelani Masondo, Mandla Zungu, Fatima Suleman and Velisha Ann Perumal-Pillay
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:2
  38. Polypharmacy is the administration of an excessive number of medicines and a significant irrational medicine use practice. Little is known about this practice in South Africa. This study aimed to determine the...

    Authors: Adetola Olaniyi Bojuwoye, Fatima Suleman and Velisha Ann Perumal-Pillay
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:1
  39. During disasters or crises, the traditional models of supply chain encounter failure and skewedness under the inevitable and unknown pressures. The procurement and transformation of required equipment to the i...

    Authors: Peivand Bastani, Omid Sadeghkhani, Ramin Ravangard, Rita Rezaei, Parisa Bikine and Gholamhossein Mehralian
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:115
  40. Variations in practice are commonplace in healthcare where health professionals, such as pharmacists act as autonomous practitioners. This is evident in simulated patient studies, where pharmacists practice do...

    Authors: Deanna Mill, Jacinta L. Johnson, Kenneth Lee, Sandra M. Salter, Danielle D’Lima, Liza Seubert, Rhonda Clifford and Amy T. Page
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:114
  41. The proportion of days covered (PDC) is used to estimate medication adherence by looking at the proportion of days in which a person has access to the medication, over a given period of interest. This study ai...

    Authors: David Prieto-Merino, Amy Mulick, Craig Armstrong, Helen Hoult, Scott Fawcett, Lina Eliasson and Sarah Clifford
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:113
  42. The Commonwealth Pharmacists Association (CPA) is a charity representing pharmacists across the Commonwealth, with the vision of empowering and collaboratively develop the profession and fully utilise the pote...

    Authors: Ayesha Iqbal, Victoria Rutter, Gizem Gülpınar, Manjula Halai, Briella Awele, Rasha Abdelsalam Elshenawy, Claire Anderson, Rabia Hussain and Amy Hai Yan Chan
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:112
  43. Community pharmacists (CPs) are increasingly facing occupational challenges as a result of the COVID-19 pandemic, putting them at high risk of burnout. This study aimed to assess the prevalence of burnout amon...

    Authors: Dalal Youssef, Janet Youssef, Hamad Hassan and Linda Abou-Abbas
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:111
  44. While having access to safe and efficient vaccines is essential for eradicating the COVID-19 pandemic, gaining marketing authorisation is a critical step in enabling and speeding this process. On December 2, 2...

    Authors: Nasir Abbas and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:110
  45. Clinical pharmacists have an important role in inter-professional healthcare collaboration for epilepsy management. However, the pharmacy practices of managing epilepsy are still limited in Vietnam, deterring ...

    Authors: Hong Tham Pham, Minh-Hoang Tran, Ngoc Quy Nguyen, Van Tan Vo and Manh Hung Tran
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:109

Annual Journal Metrics